Telehealth company HealthRight charged in $1B fraud scheme

Businessman in handcuffs with his back turned
HealthRight CEO Scott Riox pleaded guilty to felony conspiracy charges in a fraud case involving compound pharmacies. (Getty/Image Source)

The CEO of the telemedicine company HealthRight was charged alongside several compounding pharmacies for a $1 billion fraud scheme in which the company assisted with a scheme to bill insurers for marked-up pain creams and marketed other bogus supplements to patients.

HealthRight CEO Scott Roix pleaded guilty to felony conspiracy charges brought by the Department of Justice. Roix and the company also pleaded guilty to conspiring to commit wire fraud associated with a telemarketing scheme to sell dietary supplements, skin creams and testosterone to patients.

An indictment filed by federal prosecutors against four Florida men that own seven different compounding pharmacies alleges the executives deceived "tens of thousands of patients" and more than 100 doctors to defraud insurers, including Blue Cross Blue Shield of Tennessee, out of $931 million. The insurers ultimately paid out $174 million in fraudulent claims.


2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

In a statement, BCBS Tennessee said approximately $2 million in fraudulent claims were filed with the company. 

As part of the scheme, HealthRight solicited insurance coverage information and prescriptions from patients across the country for prescription pain creams. Telemedicine physicians approved the prescriptions without knowing that several compounding pharmacies were marking up the prices of the drugs, which was billed to BCBS of Tennessee. 

RELATED: After explosion of compounded drug fraud, legal experts say party's over

Separately, Riox and HealthRight used the company's telemarketing facilities to sell millions of dollars worth of fraudulent products through "concocted claims of efficacy and intentionally deficient customer service designed to stall consumer complaints."

According to its website, HealthRight connects patients with "licensed medical providers and therapeutic solutions when you need them most."

"HealthRight is a next generation health care company committed to helping people with acute or chronic health conditions get relief or treatment, fast," the company's website states.

Roix faces a statutory maximum of five years in prison for each conspiracy charge. The other four pharmacy owners—Andrew Assad, Peter Bolos, Michael Palso and Larry Everett Smith—face up to 33 years in prison. The DOJ is also seeking a forfeiture of $154 million. 

Compound pharmacies have been a hot spot for massive fraud schemes over the last several years. A recent report by the Office of Inspector General flagged concerns about the industry, noting that it warrants further scrutiny from federal officials.

Telemedicine companies, on the other hand, have largely steered clear of fraud enforcement. Monday's indictment represents a rare pockmark for the industry. 

Editor's Note: The original article misstated the amount of fraudulent claims filed with BCBS Tennessee. The article has been updated to reflect the accurate figure. 

Suggested Articles

We need our federal programs and policies to reflect the goal of improving the health of both women and men.

Two lawsuits were filed suing the Trump administration to overturn a new rule that would allow healthcare workers to deny care over religious or conscience…

Policy changes are affecting how investors view the skilled home health market and paving the way for potential strategic acquisitions.